Table of Contents Author Guidelines Submit a Manuscript
Neurology Research International
Volume 2012, Article ID 582075, 6 pages
http://dx.doi.org/10.1155/2012/582075
Clinical Study

A Pilot Trial of Pioglitazone HCl and Tretinoin in ALS: Cerebrospinal Fluid Biomarkers to Monitor Drug Efficacy and Predict Rate of Disease Progression

1Phoenix Neurological Associates, 5090 N 40th Street Suite 250, Phoenix, AZ 85018, USA
2Division of Neurology, Barrow Neurological Institute, 350 W Thomas Road, Phoenix, AZ 85013, USA
3Division of Neurogenomics, Translational Genomics Research Institute (TGen), 445 N 5th Street, Phoenix, AZ 85004, USA
4Silicon Valley Biosystems, 3000 Sand Hill Road, Menlo Park, CA 94025, USA

Received 28 March 2012; Revised 16 May 2012; Accepted 16 May 2012

Academic Editor: Kenneth Hensley

Copyright © 2012 Todd D. Levine et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Todd D. Levine, Robert Bowser, Nicole C. Hank, et al., “A Pilot Trial of Pioglitazone HCl and Tretinoin in ALS: Cerebrospinal Fluid Biomarkers to Monitor Drug Efficacy and Predict Rate of Disease Progression,” Neurology Research International, vol. 2012, Article ID 582075, 6 pages, 2012. https://doi.org/10.1155/2012/582075.